This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

LeMaitre Vascular Inc (LMAT)

NASDAQ: Health Care

$16.32 +0.71 | 4.55%
11/25/15 - 4:00:00 PM ET
  • Prev Close: 15.61
  • Day's Open: 15.71
  • Volume: 161.74K
  • Avg Vol: 132.30K
  • Shares Outstanding: 18.12M
  • Mkt Cap: 282.80M
  • Div: $0.04
  • Div Yield: 1.00%
  • P/E: 39.02
  • EPS: 0.24
LMAT Day's Range
LMAT 52 Week Range
LMAT Business Summary
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide.View LMAT key stats
LeMaitre Vascular Inc - LMAT - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates LeMaitre Vascular Inc as a Buy with a ratings score of A.
Report Snippet: We rate LEMAITRE VASCULAR INC (LMAT) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.
Rating: 4.67 out of 5, 'A' Buy.
You can view the full analysis from the report here:
LMAT Rating Report
LMAT Performance as of Prev. Close
LMAT EPS Performance
1-Yr Ago
2-Yrs Ago
3-Yrs Ago
LMAT Percentage in these ETFs

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LMAT LeMaitre Vascular Inc

Chart of LMAT

Analysts Ratings for LMAT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 4 4
Moderate Buy 1 1 1 1
Hold 0 1 1 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

LMAT Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs